Company Profile
Updated: 17-SEP-09Biopure Corp.
Public Company, Headquarters Location
11 Hurley St., Cambridge, MA 02141-2110, United States
(617)234-6500, (617)234-6505 fax, http://www.biopure.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Therapeutic oxygen, pharmaceutical research and development. Services: Commercial physical and biological research and development.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Rising market tide fails to lift some Mass. firms
The Boston Globe; 11/13/2009; 965 words; ...their shareholders? Some companies on the list, such as Biopure Corp. of Cambridge and Altus Pharmaceuticals Inc. of Waltham...support its business operations through 2013. Genzyme Corp. of Cambridge, by far the biggest and best-known company...
Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 1202 words; Adolor Corp., of Exton, Pa., appointed Martha...commercial officer, global operations. Biopure Corp., of Cambridge, Mass., added Barry...vaccine research and development. CytRx Corp., of Los Angeles, elected Louis Ignarro...
Lexicon Leads Financing Spree With Public Offering Netting $49M.
BIOWORLD Today; 11/4/2009; 1353 words; ...cash equivalents at that point. Investment In Biopure To Further Oxygen Therapeutics Biopure Corp. grossed $17.2 million through the sale...capital needs. Based in Cambridge, Mass., Biopure develops oxygen therapeutics, a new class...
Other News To Note.
BIOWORLD Today; 11/4/2009; 3015 words; ...Pa., a subsidiary of Cytogen Corp., signed a term sheet with the...all joint intellectual property. Biopure Corp., of Cambridge, Mass., sold...proceeds of about $20.7 million. Biopure will use the estimated net proceeds...
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 916 words; ...study for foot and ankle fusions and its Swedish pilot study to evaluate the treatment of distal radius fractures. o Biopure Corp., of Cambridge, Mass., submitted a marketing authorization application to the UK's Medicines and Healthcare Products...
Recent News Articles
- Biopure Corporation Receives Notice of Delisting from Nasdaq.
Biotech Week - August 05, 2009 - Biopure Corporation Receives Notice of Delisting from Nasdaq.
PR Newswire - July 17, 2009 - Biopure Corporation - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Biopure Corp. Review in Progress.
M2 Presswire - April 11, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning